Essential Partners’s Kura Oncology KURA Stock Holding History

Essential Partners’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$33.5K	Sell	3,126 -33	-1%	-$369	0.02%	748
2026 Q2	$34.7K	Sell	3,159 -3,407	-52%	-$32.1K	0.02%	709
2026 Q1	$53.4K	Sell	6,566 -5,137	-44%	-$44.1K	0.02%	585
2025 Q4	$122K	Buy	11,703 +3,539	+43%	+$37.1K	0.04%	402
2025 Q3	$72.3K	Buy	8,164 +6,050	+286%	+$43.1K	0.02%	511
2025 Q2	$12.2K	Buy	+2,114	New	+$13K	﹤0.01%	794

Other funds holding KURA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

FCC

Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners's KURA Position: Q3 2026 in Review

Essential Partners reduced its Kura Oncology (KURA) stake by 1% in Q3 2026, selling an estimated $369 and leaving 3,126 shares worth $33.5K. The position accounts for 0.02% of the portfolio, ranked #748.

Essential Partners first reported a position in KURA in Q2 2025 and has held it in 6 quarters since. The position peaked at $122K in Q4 2025. 20 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

Essential Partners held 3,126 shares of Kura Oncology worth $33.5K as of Q3 2026.
Essential Partners sold 33 Kura Oncology shares in Q3 2026, an estimated $369.
Kura Oncology made up 0.02% of Essential Partners's portfolio in Q3 2026, its #748 holding.
Essential Partners first reported a position in Kura Oncology in Q2 2025 and has held it in 6 quarters since.
Essential Partners's Kura Oncology position peaked at $122K in Q4 2025.
20 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.